Southport Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-6,100
Closed -$329K 49
2016
Q3
$329K Sell
6,100
-17,500
-74% -$1.12M 0.64% 30
2016
Q2
$1.74M Sell
23,600
-10,000
-30% -$707K 3.49% 12
2016
Q1
$2.15M Sell
33,600
-16,400
-33% -$1.03M 3.55% 9
2015
Q4
$3.44M Hold
50,000
6.09% 3
2015
Q3
$2.96M Hold
50,000
5.98% 5
2015
Q2
$3.33M Sell
50,000
-10,000
-17% -$659K 4.29% 5
2015
Q1
$3.87M Hold
60,000
4.05% 7
2014
Q4
$3.54M Buy
+60,000
New +$3.38M 3.74% 7

Other funds holding BMY

Southport Management's BMY Position: Q4 2016 in Review

Southport Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 6,100 shares — an estimated $329K sold.

Southport Management first reported a position in BMY in Q4 2014 and held it in 8 quarters. The position peaked at $3.87M in Q1 2015. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • Southport Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
  • Southport Management sold 6,100 Bristol-Myers Squibb shares in Q4 2016, an estimated $329K.
  • Southport Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 8 quarters.
  • Southport Management's Bristol-Myers Squibb position peaked at $3.87M in Q1 2015.
  • 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Southport Management's 13F filing for Q4 2016, filed 14 Feb 2017.